Biochemistry and cell signaling taught by bacterial effectors

Trends in Biochemical Sciences

Volumn 36, Issue 10, 2011, Pages 532-540

  Cui, Jixin ^a   Shao, Feng ^a  

^a NATIONAL INSTITUTE OF BIOLOGICAL SCIENCES   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ACYLTRANSFERASE; CIF PROTEIN; DRRA PROTEIN; GUANOSINE TRIPHOSPHATASE; IBPA PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IPAH PROTEIN; LYASE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE; NEDD8 PROTEIN; OSPF PRTOEIN; RAB PROTEIN; SIDM PROTEIN; TRANSFERASE; UBIQUITIN; UBIQUITIN PROTEIN LIGASE; UNCLASSIFIED DRUG; VOPS PROTEIN; YOPJ PROTEIN;

ACETYLATION; ADENYLATION; BACTERIAL VIRULENCE; BIOCHEMISTRY; CYTOPATHOGENIC EFFECT; DEAMINATION; ENZYME ACTIVATION; MEMBRANE TRANSPORT; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; REVIEW; SIGNAL TRANSDUCTION; TYPE III SECRETION SYSTEM; UBIQUITINATION;

ANIMALS; BACTERIA; BACTERIAL PROTEINS; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASES; NUCLEOTIDYLTRANSFERASES; PHOSPHORYLATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; SIGNAL TRANSDUCTION; UBIQUITINATION; VIRULENCE FACTORS;

BACTERIA (MICROORGANISMS); EUKARYOTA;

EID: 80053337001     PISSN: 09680004     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tibs.2011.07.003     Document Type: Review

References (85)

1. Galan J.E., Wolf-Watz H. Protein delivery into eukaryotic cells by type III secretion machines. Nature 2006, 444:567-573.
2. Wallden K., et al. Type IV secretion systems: versatility and diversity in function. Cell Microbiol. 2010, 12:1203-1212.
3. Bhavsar A.P., et al. Manipulation of host-cell pathways by bacterial pathogens. Nature 2007, 449:827-834.
4. Spallek T., et al. How microbes utilize host ubiquitination. Cell Microbiol. 2009, 11:1425-1434.
5. Arbibe L., et al. An injected bacterial effector targets chromatin access for transcription factor NF-kappaB to alter transcription of host genes involved in immune responses. Nat. Immunol. 2007, 8:47-56.
6. Kramer R.W., et al. Yeast functional genomic screens lead to identification of a role for a bacterial effector in innate immunity regulation. PLoS Pathog. 2007, 3:e21.
7. Li H., et al. The phosphothreonine lyase activity of a bacterial type III effector family. Science 2007, 315:1000-1003.
8. Mazurkiewicz P., et al. SpvC is a Salmonella effector with phosphothreonine lyase activity on host mitogen-activated protein kinases. Mol. Microbiol. 2008, 67:1371-1383.
9. Brennan D.F., Barford D. Eliminylation: a post-translational modification catalyzed by phosphothreonine lyases. Trends Biochem. Sci. 2009, 34:108-114.
10. Zhu Y., et al. Structural insights into the enzymatic mechanism of the pathogenic MAPK phosphothreonine lyase. Mol. Cell 2007, 28:899-913.
11. Willey J.M., van der Donk W.A. Lantibiotics: peptides of diverse structure and function. Annu. Rev. Microbiol. 2007, 61:477-501.
12. Goto Y., et al. Mechanistic studies of Ser/Thr dehydration catalyzed by a member of the LanL lanthionine synthetase family. Biochemistry 2011, 50:891-898.
13. Garrido-Franco M., et al. Structure and function of threonine synthase from yeast. J. Biol. Chem. 2002, 277:12396-12405.
14. Donini S., et al. A threonine synthase homolog from a mammalian genome. Biochem. Biophys. Res. Commun. 2006, 350:922-928.
15. Orth K. Function of the Yersinia effector YopJ. Curr. Opin. Microbiol. 2002, 5:38-43.
16. Mittal R., et al. Acetylation of MEK2 and I kappa B kinase (IKK) activation loop residues by YopJ inhibits signaling. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:18574-18579.
17. Mukherjee S., et al. Yersinia YopJ acetylates and inhibits kinase activation by blocking phosphorylation. Science 2006, 312:1211-1214.
18. Jones R.M., et al. Salmonella AvrA coordinates suppression of host immune and apoptotic defenses via JNK pathway blockade. Cell Host Microbe 2008, 3:233-244.
19. Du F., Galan J.E. Selective inhibition of type III secretion activated signaling by the Salmonella effector AvrA. PLoS Pathog. 2009, 5:e1000595.
20. Fehr D., et al. AopP, a type III effector protein of Aeromonas salmonicida, inhibits the NF-kappaB signalling pathway. Microbiology 2006, 152:2809-2818.
21. Trosky J.E., et al. VopA inhibits ATP binding by acetylating the catalytic loop of MAPK kinases. J. Biol. Chem. 2007, 282:34299-34305.
22. Johnson C.M., et al. The serine acetyltransferase reaction: acetyl transfer from an acylpantothenyl donor to an alcohol. Arch. Biochem. Biophys. 2005, 433:85-95.
23. Tasset C., et al. Autoacetylation of the Ralstonia solanacearum effector PopP2 targets a lysine residue essential for RRS1-R-mediated immunity in Arabidopsis. PLoS Pathog. 2010, 6:e1001202.
24. Mukherjee S., et al. A newly discovered post-translational modification - the acetylation of serine and threonine residues. Trends Biochem. Sci. 2007, 32:210-216.
25. Mittal R., et al. The acetyltransferase activity of the bacterial toxin YopJ of Yersinia is activated by eukaryotic host cell inositol hexakisphosphate. J. Biol. Chem. 2010, 285:19927-19934.
26. Hao Y.H., et al. Structural requirements for Yersinia YopJ inhibition of MAP kinase pathways. PLoS ONE 2008, 3:e1375.
27. Rabut G., Peter M. Function and regulation of protein neddylation. EMBO Rep. 2008, 9:969-976.
28. Ashida H., et al. Shigella chromosomal IpaH proteins are secreted via the type III secretion system and act as effectors. Mol. Microbiol. 2007, 63:680-693.
29. Rohde J.R., et al. Type III secretion effectors of the IpaH family are E3 ubiquitin ligases. Cell Host Microbe 2007, 1:77-83.
30. Singer A.U., et al. Structure of the Shigella T3SS effector IpaH defines a new class of E3 ubiquitin ligases. Nat. Struct. Mol. Biol. 2008, 15:1293-1301.
31. Zhu Y., et al. Structure of a Shigella effector reveals a new class of ubiquitin ligases. Nat. Struct. Mol. Biol. 2008, 15:1302-1308.
32. Quezada C.M., et al. A family of Salmonella virulence factors functions as a distinct class of autoregulated E3 ubiquitin ligases. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:4864-4869.
33. Levin I., et al. Identification of an unconventional E3 binding surface on the UbcH5-Ub conjugate recognized by a pathogenic bacterial E3 ligase. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:2848-2853.
34. Seyedarabi A., et al. A disulfide driven domain swap switches off the activity of Shigella IpaH9.8 E3 ligase. FEBS Lett. 2010, 584:4163-4168.
35. Haraga A., Miller S.I. A Salmonella type III secretion effector interacts with the mammalian serine/threonine protein kinase PKN1. Cell Microbiol. 2006, 8:837-846.
36. Ashida H., et al. A bacterial E3 ubiquitin ligase IpaH9.8 targets NEMO/IKKgamma to dampen the host NF-kappaB-mediated inflammatory response. Nat. Cell Biol. 2010, 12:66-73.
37. Hsu Y., et al. Structure of the cyclomodulin Cif from pathogenic Escherichia coli. J. Mol. Biol. 2008, 384:465-477.
38. Jubelin G., et al. Cycle inhibiting factors (CIFs) are a growing family of functional cyclomodulins present in invertebrate and mammal bacterial pathogens. PLoS ONE 2009, 4:e4855.
39. Yao Q., et al. A bacterial type III effector family uses the papain-like hydrolytic activity to arrest the host cell cycle. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:3716-3721.
40. Crow A., et al. Crystal structures of Cif from bacterial pathogens Photorhabdus luminescens and Burkholderia pseudomallei. PLoS ONE 2009, 4:e5582.
41. Cui J., et al. Glutamine deamidation and dysfunction of ubiquitin/NEDD8 induced by a bacterial effector family. Science 2010, 329:1215-1218.
42. Jubelin G., et al. Pathogenic bacteria target NEDD8-conjugated cullins to hijack host-cell signaling pathways. PLoS Pathog. 2010, 6.
43. Morikawa H., et al. The bacterial effector Cif interferes with SCF ubiquitin ligase function by inhibiting deneddylation of cullin1. Biochem. Biophys. Res. Commun. 2010, 401:268-274.
44. Duda D.M., et al. Structural insights into NEDD8 activation of cullin-RING ligases: conformational control of conjugation. Cell 2008, 134:995-1006.
45. Chen Y., et al. Cullin mediates degradation of RhoA through evolutionarily conserved BTB adaptors to control actin cytoskeleton structure and cell movement. Mol. Cell 2009, 35:841-855.
46. Segev N. Coordination of intracellular transport steps by GTPases. Semin Cell Dev. Biol. 2011, 22:33-38.
47. Aktories K., Barbieri J.T. Bacterial cytotoxins: targeting eukaryotic switches. Nat. Rev. Microbiol. 2005, 3:397-410.
48. Woolery A.R., et al. AMPylation: something old is new again. Front Microbiol. 2010, 1:113.
49. Itzen A., et al. Adenylylation: renaissance of a forgotten post-translational modification. Trends Biochem. Sci. 2011, 36:221-228.
50. Casselli T., et al. Vibrio parahaemolyticus inhibition of Rho family GTPase activation requires a functional chromosome I type III secretion system. Infect. Immun. 2008, 76:2202-2211.
51. Yarbrough M.L., et al. AMPylation of Rho GTPases by Vibrio VopS disrupts effector binding and downstream signaling. Science 2009, 323:269-272.
52. Worby C.A., et al. The Fic domain: regulation of cell signaling by adenylylation. Mol. Cell 2009, 34:93-103.
53. Luong P., et al. Kinetic and structural insights into the mechanism of AMPylation by VopS Fic domain. J. Biol. Chem. 2010, 285:20155-20163.
54. Xiao J., et al. Structural basis of Fic-mediated adenylylation. Nat. Struct. Mol. Biol. 2010, 17:1004-1010.
55. Palanivelu D.V., et al. Fic domain-catalyzed adenylylation: insight provided by the structural analysis of the type IV secretion system effector BepA. Protein Sci. 2011, 20:492-499.
56. Isberg R.R., et al. The Legionella pneumophila replication vacuole: making a cosy niche inside host cells. Nat. Rev. Microbiol. 2009, 7:13-24.
57. Machner M.P., Isberg R.R. Targeting of host Rab GTPase function by the intravacuolar pathogen Legionella pneumophila. Dev. Cell 2006, 11:47-56.
58. Murata T., et al. The Legionella pneumophila effector protein DrrA is a Rab1 guanine nucleotide-exchange factor. Nat. Cell Biol. 2006, 8:971-977.
59. Ingmundson A., et al. Legionella pneumophila proteins that regulate Rab1 membrane cycling. Nature 2007, 450:365-369.
60. Machner M.P., Isberg R.R. A bifunctional bacterial protein links GDI displacement to Rab1 activation. Science 2007, 318:974-977.
61. Schoebel S., et al. RabGDI displacement by DrrA from Legionella is a consequence of its guanine nucleotide exchange activity. Mol. Cell 2009, 36:1060-1072.
62. Suh H.Y., et al. Structural insights into the dual nucleotide exchange and GDI displacement activity of SidM/DrrA. EMBO J. 2010, 29:496-504.
63. Zhu Y., et al. Structural mechanism of host Rab1 activation by the bifunctional Legionella type IV effector SidM/DrrA. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:4699-4704.
64. Muller M.P., et al. The Legionella effector protein DrrA AMPylates the membrane traffic regulator Rab1b. Science 2010, 329:946-949.
65. Xu Y., et al. Structure of the adenylylation domain of E. coli glutamine synthetase adenylyl transferase: evidence for gene duplication and evolution of a new active site. J. Mol. Biol. 2010, 396:773-784.
66. Jaggi R., et al. The two opposing activities of adenylyl transferase reside in distinct homologous domains, with intramolecular signal transduction. EMBO J. 1997, 16:5562-5571.
67. Hao Y.H., et al. Characterization of a rabbit polyclonal antibody against threonine-AMPylation. J. Biotechnol. 2011, 151:251-254.
68. Selyunin A.S., et al. The assembly of a GTPase-kinase signalling complex by a bacterial catalytic scaffold. Nature 2011, 469:107-111.
69. Germane K.L., Spiller B.W. Structural and functional studies indicate that the EPEC effector, EspG, directly binds p21-activated kinase. Biochemistry 2011, 50:917-919.
70. Alto N.M., et al. The type III effector EspF coordinates membrane trafficking by the spatiotemporal activation of two eukaryotic signaling pathways. J. Cell Biol. 2007, 178:1265-1278.
71. Vingadassalom D., et al. Insulin receptor tyrosine kinase substrate links the E. coli O157:H7 actin assembly effectors Tir and EspF(U) during pedestal formation. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:6754-6759.
72. Weiss S.M., et al. IRSp53 links the enterohemorrhagic E. coli effectors Tir and EspFU for actin pedestal formation. Cell Host Microbe 2009, 5:244-258.
73. Vingadassalom D., et al. Enterohemorrhagic E. coli requires N-WASP for efficient type III translocation but not for EspFU-mediated actin pedestal formation. PLoS Pathog. 2010, 6.
74. Stein M.A., et al. Identification of a Salmonella virulence gene required for formation of filamentous structures containing lysosomal membrane glycoproteins within epithelial cells. Mol. Microbiol. 1996, 20:151-164.
75. Ruiz-Albert J., et al. Complementary activities of SseJ and SifA regulate dynamics of the Salmonella typhimurium vacuolar membrane. Mol. Microbiol. 2002, 44:645-661.
76. Freeman J.A., et al. The Salmonella enterica serovar typhimurium translocated effectors SseJ and SifB are targeted to the Salmonella-containing vacuole. Infect. Immun. 2003, 71:418-427.
77. Boucrot E., et al. Salmonella typhimurium SifA effector protein requires its membrane-anchoring C-terminal hexapeptide for its biological function. J. Biol. Chem. 2003, 278:14196-14202.
78. Reinicke A.T., et al. A Salmonella typhimurium effector protein SifA is modified by host cell prenylation and S-acylation machinery. J. Biol. Chem. 2005, 280:14620-14627.
79. Ohlson M.B., et al. Structure and function of Salmonella SifA indicate that its interactions with SKIP, SseJ, and RhoA family GTPases induce endosomal tubulation. Cell Host Microbe 2008, 4:434-446.
80. Diacovich L., et al. Interaction between the SifA virulence factor and its host target SKIP is essential for Salmonella pathogenesis. J. Biol. Chem. 2009, 284:33151-33160.
81. Dumont A., et al. SKIP, the host target of the Salmonella virulence factor SifA, promotes kinesin-1-dependent vacuolar membrane exchanges. Traffic 2010, 11:899-911.
82. Ohlson M.B., et al. SseJ deacylase activity by Salmonella enterica serovar Typhimurium promotes virulence in mice. Infect. Immun. 2005, 73:6249-6259.
83. Lossi N.S., et al. The Salmonella SPI-2 effector SseJ exhibits eukaryotic activator-dependent phospholipase A and glycerophospholipid: cholesterol acyltransferase activity. Microbiology 2008, 154:2680-2688.
84. Nawabi P., et al. Esterification of cholesterol by a type III secretion effector during intracellular Salmonella infection. Mol. Microbiol. 2008, 68:173-185.
85. Christen M., et al. Activation of a bacterial virulence protein by the GTPase RhoA. Sci. Signal. 2009, 2:ra71.